Syverson Strege & Co’s Labcorp LH Stock Holding History

Syverson Strege & Co’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-10	Closed	-$2.06K	–	373
2023 Q1	$2.06K	Buy	+10	New	+$2.06K	﹤0.01%	485
2021 Q4	–	Sell	-28	Closed	-$7K	–	407
2021 Q3	$7K	Buy	+28	New	+$7.06K	0.01%	281

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Syverson Strege & Co's LH Position: Q2 2023 in Review

Syverson Strege & Co sold out of Labcorp (LH) in Q2 2023, closing a stake of 10 shares — an estimated $2.06K sold.

Syverson Strege & Co first reported a position in LH in Q3 2021 and held it in 2 quarters. The position peaked at $7K in Q3 2021. 932 funds tracked by Wall St. Rank hold LH as of Q2 2023.

Syverson Strege & Co reported no remaining Labcorp position as of Q2 2023 after selling out during the quarter.
Syverson Strege & Co sold 10 Labcorp shares in Q2 2023, an estimated $2.06K.
Syverson Strege & Co first reported a position in Labcorp in Q3 2021 and held it in 2 quarters.
Syverson Strege & Co's Labcorp position peaked at $7K in Q3 2021.
932 funds tracked by Wall St. Rank held Labcorp as of Q2 2023.

Based on Syverson Strege & Co's 13F filing for Q2 2023, filed 4 Aug 2023.